GO
Loading...

Life Sciences

More

  • DSM Chairman and CEO Feike Sijbesma told CNBC he expects the Dutch chemicals firm to perform well in the second half of the year following strong second quarter results which saw a boost in net profit, while revenue fell just shy of the Reuters average forecast.

  • Life Sciences Wire Story Sunday, 1 Dec 2002 | 12:00 AM ET